生产、销售劣药罪的立法模式评析——以山东问题疫苗事件为切入点

发布时间：2018-05-17 08:53

本文选题：生产、销售劣药罪 + 假药　；参考：《上海政法学院学报(法治论丛)》2016年03期

【摘要】：考察我国刑法关于药品安全刑事法律规范沿革可以看出,我国刑法在生产、销售假药罪与生产、销售劣药罪的社会危害性严重程度的认定上前后矛盾,生产、销售假药罪与生产、销售劣药罪刑事责任的差距逐渐扩大,并且假药、劣药如何区分仍未得到解决。司法实践中生产、销售劣药犯罪案件极少,原因在于假药劣药范畴模糊,结果犯的立法模式无法应对生产、销售劣药罪的实务需求以及行政执法与刑事司法衔接机制不完善。从严厉惩治生产、销售劣药犯罪行为及完善药品犯罪刑法体系角度出发,有必要取消我国刑法中假药、劣药二元标准的立法模式,取消生产、销售劣药罪,将劣药纳入假药范畴。
[Abstract]:By examining the evolution of the criminal law on drug safety in the criminal law of our country, we can see that the criminal law of our country is inconsistent in the determination of the degree of social harmfulness of the crime of producing, selling counterfeit drugs and the crime of producing and selling inferior drugs. The criminal liability gap between the crime of selling counterfeit drugs and the crimes of producing and selling inferior drugs has gradually widened, and the distinction between counterfeit drugs and inferior drugs has not been solved. In judicial practice, there are few cases of producing and selling inferior drugs, the reason is that the category of counterfeit and inferior drugs is vague, the legislative model of the resulting crime cannot cope with the production, the practical demand of the crime of selling inferior drugs and the connection mechanism between administrative law enforcement and criminal justice are not perfect. From the angle of severely punishing the criminal behavior of producing and selling inferior drugs and perfecting the criminal law system of drug crimes, it is necessary to abolish the legislative model of dualistic standards of counterfeit and inferior drugs in the criminal law of our country, and cancel the crime of producing and selling inferior drugs. Bring substandard medicine into the category of counterfeit medicine.
【作者单位】：福建省厦门市集美区人民法院;
【分类号】：D924.3

【相似文献】